Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer

Journal of the National Cancer Institute

Volumn 88, Issue 5, 1996, Pages 270-278

  Hawkins, Michael M ^a   Kinnier Wilson, L Margaret ^a   Burton, Hazel S ^a   Potok, Michael H N ^a   Winter, David L ^a   Marsden, H Basil ^b   Stovall, Marilyn A ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; ANTINEOPLASTIC ANTIBIOTIC; ASPARAGINASE; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CHLORMETHINE DERIVATIVE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN; LOMUSTINE; MITHRAMYCIN; PROCARBAZINE; TRETAMINE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ADULT; ARTICLE; BONE CANCER; CANCER RADIOTHERAPY; CANCER RISK; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; EWING SARCOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; RADIATION DOSE; RETINOBLASTOMA; SECOND CANCER;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETINOBLASTOMA; RISK; SARCOMA, EWING'S;

EID: 13344261408     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.5.270     Document Type: Article

References (15)

1. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987;56:339-47.
2. Cotter FE, Pritchard J. Clonality in Langerhans' cell histiocytosis [editorial] [see comment citations in BJM 1995;310:80-5]. BMJ 1995; 310:74-5.
3. Hawkins MM, Swerdlow AJ. Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales. Br J Cancer 1992;66:408-13.
4. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci Publ 82:1-406.
5. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
6. Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 32:5-338.
7. EGRET reference manual. Seattle: Statistics and Epidemiology Research Corporation, 1990.
8. Tucker MA, Meadows AT, Boice JD Jr, Stovall M, Oberlin O, Stone BJ, et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987;78:459-64.
9. Tucker MA, Meadows AT, Boice JD, Hoover RN, Fraumeni JF Jr. Cancer risk following treatment of childhood cancer. In: Boice JD, Fraumemi JF, editors. Radiation carcinogenesis: epidemiology and biological significance. New York: Raven Press, 1984:211-24.
10. Tucker MA, D'Angio GJ, Boice JD Jr. Strong LC Li FP, Stovall M, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987;317:588-93.
11. Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, et al. Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 1993;307:1030-6.
12. de Vathaire F, Schweisguth O, Rodary C, Francois P, Sarrazin D, Oberlin O, et al. Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer 1989;59:448-52.
13. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong L, Goldman MB. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85:1121-8.
14. Draper GJ, Sanders BM, Brownbill PA, Hawkins MM. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br J Cancer 1992;66:211-9.
15. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with Ewing's sarcoma [letter] [see comment citation in Med Pediatr Oncol 1994;22:6-12]. Med Pediatr Oncol 1994;22:296-7.